Technical Analysis for BOT - Botanix Pharmaceuticals Ltd  

Grade Last Price % Change Price Change
C 0.320 0.00% 0.000
BOT closed unchanged on Thursday, November 14, 2024, on 1.55 times normal volume.
10 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Gapped Up Strength 0.00%
Inside Day Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -1.54%
20 DMA Resistance Bearish -4.48%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.48%
Doji - Bearish? Reversal -4.48%
Gapped Down Weakness -4.48%
20 DMA Resistance Bearish -5.88%

   Recent Intraday Alerts

Alert Time
Gap Up Closed about 11 hours ago
10 DMA Resistance about 13 hours ago
10 DMA Support about 13 hours ago
20 DMA Resistance about 13 hours ago
Possible Pocket Pivot about 13 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Botanix Pharmaceuticals Ltd   Description

Botanix Pharmaceuticals Limited, formerly Bone Medical Limited, is a pharmaceutical company. The Company focuses on developing medical dermatology products for dermatologists and their patients. Its segments include Research & Development and Corporate. The Company's products and pipeline products are all based on drug delivery technology known as Permetrex, which helps solve the challenge of delivering active pharmaceutical ingredients across the skin. The Company's products, which are under development, are focused on modulating the body's endocannabinoid system of receptors which regulates skin function, growth and renewal. Its product pipeline includes BTX1503, BTX1308 and BTX1204. Its BTX1503 is a transdermal gel formulation used for the treatment of serious acne in adults and teenagers. Its BTX1308 is a transdermal gel formulation used for the treatment of plaque psoriasis. Its BTX1204 is a transdermal gel formation used for the treatment of atopic dermititis.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Pharmaceuticals Health Sciences Rex Drug Delivery Pharmacology Transdermal Acne Active Pharmaceutical Ingredients Routes Of Administration

Is BOT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.445
52 Week Low 0.1375
Average Volume 6,101,307
200-Day Moving Average 0.299
50-Day Moving Average 0.366
20-Day Moving Average 0.334
10-Day Moving Average 0.327
Average True Range 0.019
RSI (14) 41.18
ADX 19.79
+DI 19.627
-DI 20.503
Chandelier Exit (Long, 3 ATRs) 0.309
Chandelier Exit (Short, 3 ATRs) 0.366
Upper Bollinger Bands 0.359
Lower Bollinger Band 0.308
Percent B (%b) 0.24
BandWidth 15.532
MACD Line -0.011
MACD Signal Line -0.011
MACD Histogram 0.0002
Fundamentals Value
Market Cap 311.26 Million
Num Shares 973 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -14.55
Price-to-Sales 0.00
Price-to-Book 4.73
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.361
Resistance 3 (R3) 0.365 0.356 0.354
Resistance 2 (R2) 0.356 0.346 0.354 0.351
Resistance 1 (R1) 0.338 0.339 0.334 0.334 0.349
Pivot Point 0.329 0.329 0.327 0.327 0.329
Support 1 (S1) 0.311 0.319 0.307 0.307 0.291
Support 2 (S2) 0.302 0.312 0.300 0.289
Support 3 (S3) 0.284 0.302 0.286
Support 4 (S4) 0.280